home / stock / cslly / cslly news


CSLLY News and Press, CSL Ltd ADR From 09/13/23

Stock Information

Company Name: CSL Ltd ADR
Stock Symbol: CSLLY
Market: OTC

Menu

CSLLY CSLLY Quote CSLLY Short CSLLY News CSLLY Articles CSLLY Message Board
Get CSLLY Alerts

News, Short Squeeze, Breakout and More Instantly...

CSLLY - Expected US Company Earnings on Wednesday, September 13th, 2023

Software AG ADR (STWRY) is expected to report for Q2 2023 Dai Nippon Printing Co Ltd ADR (DNPLY) is expected to report for quarter end 2023-06-30 Coffee Holding Co. Inc. (JVA) is expected to report for Q1 2024 Calloway`s Nursery, Inc. (CLWY) is expected to report for Q2 2023 Home ...

CSLLY - Expected US Company Earnings on Wednesday, September 6th, 2023

Sportsman's Warehouse Holdings Inc. (SPWH) is expected to report $0.02 for Q2 2024 Screen Holdings Co. Ltd. (DINRF) is expected to report for Q1 2024 Bionik Laboratories Corp (BNKL) is expected to report for Q1 2024 Atento S.A. (ATTOF) is expected to report for Q2 2023 Akoustis Te...

CSLLY - Arcturus, CSL granted EU review for COVID vaccine

2023-09-05 10:13:43 ET More on Arcturus, CSL, etc. CSL: Watch Out For Positive Surprises CSL Limited ( OTCQX:CSLLY ) Q4 2023 Earnings Call Transcript CSL Limited 2023 Q4 - Results - Earnings Call Presentation Arcturus Therapeutics Holdings Inc. ( ARCT...

CSLLY - CSL: Watch Out For Positive Surprises

2023-09-04 07:52:46 ET Summary CSL Limited has left its current fiscal year financial guidance unchanged, which I deem to be too conservative. There are various indicators suggesting that the company's actual topline expansion and profit margin improvement might surprise the marke...

CSLLY - CSL Seqirus Announces Third U.S. Government Award in Relation to Influenza A(H5N8) Candidate Vaccine

CSL Seqirus Announces Third U.S. Government Award in Relation to Influenza A(H5N8) Candidate Vaccine PR Newswire CSL Seqirus will deliver further H5N8 A/Astrakhan antigen to support the U.S. government's pandemic preparedness activities This is the third influenza pandemic...

CSLLY - Ferinject® granted upgraded recommendations in 2023 ESC heart failure guidelines

Ferinject® granted upgraded recommendations in 2023 ESC heart failure guidelines Canada NewsWire The 2023 European Society of Cardiology (ESC) guidelines for acute and chronic heart failure (HF) include upgraded recommendations for intravenous (IV) iron supplementation, inc...

CSLLY - CSL Appoints Jeffrey Ball as First Chief Sustainability Officer

CSL Appoints Jeffrey Ball as First Chief Sustainability Officer PR Newswire MELBOURNE, Australia , Aug. 17, 2023 /PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) (USOTC: CSLLY) announced today that Jeffrey Ball , an established global leader acr...

CSLLY - CSL Limited NPATA of $2.38B, revenue of $13.31B

2023-08-15 12:03:03 ET CSL Limited press release ( OTCQX:CSLLY ): FY NPATA of $2.38B. Revenue of $13.31B (+26.0% Y/Y). For further details see: CSL Limited NPATA of $2.38B, revenue of $13.31B

CSLLY - CSL Limited (CSLLY) Q4 2023 Earnings Call Transcript

2023-08-15 02:37:06 ET CSL Limited (CSLLY) Q4 2023 Earnings Conference Call August 14, 2023 09:00 PM ET Company Participants Mark Dehring - Head of Investor Relations Paul McKenzie - Chief Executive Officer Joy Linton - Chief Financial Officer Bill Campbell -...

CSLLY - Stick to U.S. stocks that offer experience over hope, Goldman says

2023-08-02 06:46:35 ET More on market strategy My Current View Of The S&P 500 Index: August 2023 Edition (Technical Analysis) Avi Gilburt Warns Of Potential Banking Crisis; Charts Indicate Major Disruptions Morgan Stanley bear Wilson sees a 2019-like rally this y...

Previous 10 Next 10